Background-Recent evidence indicates that membrane voltage and Ca 2ϩ clocks jointly regulate sinoatrial node (SAN) automaticity. Here we test the hypothesis that sinus rate acceleration by ␤-adrenergic stimulation involves synergistic interactions between these clock mechanisms. Methods and Results-We simultaneously mapped intracellular calcium (Ca i ) and membrane potential in 25 isolated canine right atrium, using previously described criteria of the timing of late diastolic Ca i elevation (LDCAE) relative to the action potential upstroke to detect the Ca 2ϩ clock. Before isoproterenol, the earliest pacemaking site occurred in the inferior SAN, and LDCAE was observed in only 4 of 25 preparations. Isoproterenol infusion (1 mol/L) increased sinus rate and shifted pacemaking site to superior SAN, concomitant with the appearance of LDCAE preceding the action potential upstroke by 98Ϯ31 ms. Caffeine had similar effects, whereas sarcoplasmic reticulum Ca 2ϩ depletion with ryanodine and thapsigargin prevented isoproterenol-induced LDCAE and blunted sinus rate acceleration. Ca i transient relaxation time during isoproterenol was shorter in superior SAN (124Ϯ34 ms) than inferior SAN (138Ϯ24 ms; Pϭ0.01) or right atrium (164Ϯ33 ms; Pϭ0.001) and was associated with a lower sarcoplasmic reticulum Ca 2ϩ ATPase pump to phospholamban protein ratio in SAN than in right atrium. Hyperpolarization-activated pacemaker current (I f ) blockade with ZD 7288 modestly blunted but did not prevent LDCAE or sinus rate acceleration by isoproterenol. Conclusions-Acceleration of the Ca 2ϩ clock in the superior SAN plays an important role in sinus acceleration during ␤-adrenergic stimulation, interacting synergistically with the voltage clock to increase sinus rate. (Circulation. 2009;119:788-796.)
S pontaneous diastolic depolarization (DD) of sinoatrial node (SAN) cells periodically initiates action potentials (APs) to set the rhythm of the heart. The mechanism of spontaneous DD has traditionally been attributed to a "voltage clock" mechanism, mediated by voltage-sensitive membrane currents, such as the hyperpolarization-activated pacemaker current (I f ) regulated by cAMP. 1, 2 However, recent studies implicate a complementary "Ca 2ϩ clock" mechanism mediated by Ca 2ϩ release from the sarcoplasmic reticulum (SR) causing DD via activation of Na-Ca exchanger current (I NCX ), which coordinately regulates sinus rate along with the voltage clock. [3] [4] [5] [6] [7] [8] [9] [10] [11] Because the intact SAN is a heterogeneous structure that includes multiple different cell types interacting with each other, the relative importance of the voltage and Ca 2ϩ clocks for pacemaking in different regions of the SAN, and in response to neurohumoral stimuli such as ␤-agonists, may be different. Indeed, activation maps in intact canine right atrium (RA) showed that SAN impulse origin is multicentric, 12 and sympathetic stimulation predictably results in a cranial (superior) shift of the pacemaking site in human and dogs. 13 On the basis of evidence from isolated SAN myocytes showing that late diastolic Ca elevation (LDCAE) relative to the AP upstroke is a key signature of pacemaking by the Ca 2ϩ clock, [3] [4] [5] [6] [7] [8] [9] [10] [11] we examined whether this criterion could provide insight into the relative importance of the Ca 2ϩ and voltage clock mechanisms to pacemaking in intact SAN tissue. To test this hypothesis, we performed dual optical mapping of transmembrane potential (V m ) and intracellular calcium (Ca i ) in intact canine SAN and RA under control conditions, during isoproterenol infusion, and in response to other pharmacological interventions.
the American Heart Association. We studied isolated canine RA in 25 mongrel dogs (weight, 22 to 28 kg). The heart was rapidly excised under general anesthesia, and the right coronary artery was perfused with 37°C Tyrode's solution equilibrated with 95% O 2 and 5% CO 2 to maintain a pH of 7.4. The composition of Tyrode's solution was as follows (in mmol/L): 125 NaCl, 4.5 KCl, 0.25 MgCl 2 , 24 NaHCO 3 , 1.8 NaH 2 PO 4 , 1.8 CaCl 2 , and 5.5 glucose. The coronary perfusion pressure was regulated between 50 and 60 mm Hg. To ensure adequate atrial perfusion, all ventricular coronary branches were tied off. Both ventricles and left atrium were removed. Contractility was inhibited by 10 to 17 mol/L of blebbistatin, 14 and the motion artifact was negligible even after isoproterenol infusion (online-only Data Supplement Figure I ). Pseudo-ECG was recorded with widely spaced bipolar RA electrodes with the use of isoproterenol-DAM8A (World Precision Instruments).
Dual V m and Ca i Recordings
The hearts were stained with Rhod-2-AM and RH237 (Molecular Probes, Eugene, Ore) and excited with laser light at 532 nm. 15 Fluorescence was collected with the use of 2 cameras (MiCAM Ultima, BrainVision, Tokyo, Japan) at 1 ms per frame and 100ϫ100 pixels with spatial resolution of 0.35ϫ0.35 mm 2 per pixel. After baseline spontaneous beats were mapped, pharmacological intervention was performed. Isoproterenol infusion (1 mol/L) was used in 11 of 25 dogs, including 5 dogs in which we determined the isoproterenol dose response of sinus rate. In 3 dogs, the ryanodine dose response of heart rate was evaluated. In the same dogs, we also determined the isoproterenol dose response of heart rate during ryanodine infusion of 3 mol/L. In the remaining 11 dogs, the pharmacological interventions were as follows: caffeine (20 mmol/L, 2 mL) given as a bolus injection within 1 second (nϭ2), caffeine (0.2 and 0.5 mmol/L) continuous infusion (nϭ2) including a dog with caffeine (20 mmol/L) continuous infusion, isoproterenol (1 mol/L) to induce LDCAE and then followed by ryanodine (3 mol/L) (nϭ2), ryanodine (10 mol/L) plus thapsigargin (200 nmol/L) without and then with isoproterenol infusion (1 mol/L) (nϭ2), and ZD 7288 (3 mol/L) without and then with isoproterenol infusion (1 mol/L) (nϭ3).
Histology and Calcium Handling Protein Assay
The tissues were fixed in 4% buffered formalin for 1 hour, followed by storage in 70% alcohol, processed routinely, and stained with hematoxylin and eosin and with trichrome for histopathological studies. We also performed immunostaining of HCN4 with rabbit anti-HCN4 polyclonal antibody (Santa Cruz Biotechnology Inc, Santa Cruz, Calif) at 1:100 dilution. Microscopic examination was performed to confirm the correct localization of SAN.
Superior and inferior parts of SAN and RA were collected in 4 dogs. SERCA2a and phospholamban are detected by the anti-SERCA2a monoclonal antibody 2A7A1 and the anti-phospholamban monoclonal antibody 1F1, respectively. 16 The SERCA2a/phospholamban ratio was evaluated. Antibody-binding protein bands were visualized by 125 I-protein A and quantified with a Bio-Rad Personal Fx Phosphorimager.
Data Analysis
Sinus rate was defined as the rate generated by sinus node activations confirmed with optical mapping. We used the term heart rate to describe the activation rate determined by pseudo-ECG tracings only. The Ca i and V m traces were normalized to their respective peak-to-peak amplitude for comparison of timing and morphology. The mean surface area of SAN was measured by the summation of pixel areas showing DD in V m tracing ( Figure  1A and 1B). The slopes of LDCAE (Figures 2 and 3 ) and DD during isoproterenol infusion were measured from the onsets of LDCAE and DD (red arrows, Figure 3C ) to peak levels of LDCAE and DD, respectively (broken arrows, Figure 3C ). The onsets of LDCAE and DD were defined by the time of the transition between negative to positive values in dCa i /dt and dV m /dt curves (arrows, Figure 3E ). Linear regression was used to determine the correlation between sinus rate and the LDCAE or DD slopes. The 90% Ca i relaxation time was measured from the maximum systolic Ca i to 90% reduction of Ca i . Student t tests were used to compare means between 2 groups. ANOVA with Fisher's least significant difference post hoc test was used to compare the means among 3 and 4 groups. Data were presented as meanϮSEM. A probability value of Յ0.05 was considered statistically significant.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Identification of SAN
The baseline sinus rate was 95Ϯ18 bpm (range, 81 to 134 bpm). Because SAN is subepicardial in dogs, 17 we mapped the epicardial side of the tissue ( Figure 1A ). The APs in the SAN (sites 1 to 4) exhibited spontaneous phase 4 DD (arrows in Figure 1B ), whereas the RA (sites 5 to 15) did not. Sites with DD were typically located posterior to the sulcus terminalis and along the SAN artery (dashed line in Figure  1A ). The mean surface area of SAN was 41.2Ϯ7.7 mm 2 (indicated by white colored area in Figure 1A ). The correct identification of the SAN was confirmed by histological studies ( Figure 1C ) and by immunostaining of anti-HCN4 (online-only Data Supplement Figure II ). before phase 0 of AP (0 ms), which in turn was much earlier than onset of P wave on ECG. D, The V m and Ca i ratio maps at times from Ϫ60 ms before to 180 ms after phase 0 AP of C. The LDCAE (broken arrows in frame Ϫ40 and Ϫ20 ms) was followed by the Ca i sinkhole during early diastole (solid arrow in frame 180 ms). E, Ca i and dCa i /dt (a), V m and dV m /dt (b). The onsets of LDCAE and DD are marked with arrows. Figure 2A shows the isochronal map during spontaneous sinus rhythm. Activation in the V m map was earliest in the anteroinferior region of the SAN (site c). Conduction velocity within SAN was slow, taking 21 ms for the impulse to travel from inferior SAN (dark blue line) to superior SAN (red line). The conduction velocity to the posterior sulcus terminalis was slower than to the anterior sulcus, as indicated by the crowded isochronal lines in the superior vena cava direction. The upstrokes of Ca i and V m fluorescence were nearly simultaneous ( Figure 2B and 2C), with the AP upstroke preceding the Ca i transient upstroke by an average of 2.7Ϯ2.0 ms. In comparison, during RA pacing, the AP upstroke preceded Ca i transient upstroke by 11.6Ϯ4.7 ms in the same area. Smallamplitude LDCAE was observed at inferior SAN in 4 of 25 preparations during baseline recording (arrows in Figure 2B to 2D). In the remaining 21 preparations, no LDCAE was observed at baseline. Under basal conditions, the leading pacemaker sites were located in the inferior and middle SANs in 18 and 7 preparations, respectively.
Effects of ␤-Adrenergic Stimulation
Robust LDCAE in SAN During Isoproterenol Infusion
Isoproterenol infusion resulted in an upward (cranial) shift of the earliest activation site to superior SAN (site a, Figure 3A) , coincident with the appearance of robust LDCAE (arrows in Figure 3B ) in this region in all 11 preparations. The conduction time from superior SAN (site a) to inferior SAN (site c) was 10 ms. LDCAE in the superior SAN preceded the phase 0 AP upstroke by 98.4Ϯ31.0 ms (from red arrow to 0 ms in Figure 3C ) and was associated with an acceleration of the rate of DD. In contrast, optical tracings from the inferior SAN (site c) and RA (site d) showed no LDCAE, with the Ca i transient upstroke always occurring after the AP upstroke. The patterns of activation between Ϫ60 and 180 ms of Figure  3C are shown in Figure 3D . The figure shows that the superior SAN had the earliest elevation in Ca i fluorescence (broken arrow, Ϫ40 ms, Figure 3D ). This site also showed the most rapid recovery during late diastole (arrow, 180 ms, Figure 3D ). Because the recovery of Ca i fluorescence at the superior SAN was relatively early, the optical map at 180 ms showed an area of low Ca i fluorescence surrounded by areas of high Ca i fluorescence (Ca i sinkhole).
Ca i and V m Characteristics Around the Leading Pacemaker Site
During isoproterenol infusion, LDCAE and DD slopes were steepest at the leading pacemaker site (asterisks in Figure 4A ) and progressively decreased toward the periphery of SAN. The LDCAE and DD were absent Ͼ3 mm away from the leading pacemaker site in the anterior and posterior directions ( Figure 4B and 4D) but were present up to 5 to 6 mm inferior to the leading pacemaker site ( Figure 4C and 4D). The LDCAE peak amplitude (arrow, Figure 4B ) occurred before the AP upstroke. LDCAE onset was always the earliest at the leading pacemaker site and was progressively delayed toward the periphery of SAN (online-only Data Supplement Figure IIIA) . The slope of LDCAE ( Figure 4D ) was always higher at the leading pacemaker site than other SAN sites. 
Progressive Superior Shift of Both LDCAE and Leading Pacemaker Sites
There was progressive and concomitant upward shift of both the leading pacemaker site and peak LDCAE during isoproterenol infusion ( Figure 5A ). At 95 bpm, for example, sites 4 and 5 had the most prominent LDCAE (asterisks). When the sinus rate increased to 173 bpm, however, site 2 had the most prominent LDCAE. These upward LDCAE shifts were observed in all hearts studied during isoproterenol infusion and always colocalized with the leading pacemaker site. Figure 5Ba compares the Ca i and V m tracings recorded at inferior, middle, and superior SAN as isoproterenol was increased from 0.01 to 1.0 mol/L. When sinus rate was Ͻ100 bpm, the inferior SAN served as the pacemaking site but did not show clear LDCAE. When the sinus rate progressively increased, LDCAE (asterisks) appeared in the middle and then superior regions as the pacemaking sites progressively moved upward. The superior SAN served as the leading pacemaker site at sinus rates Ͼ120 bpm. The LDCAE and DD slopes in the superior SAN showed a significant positive correlation with the increase of sinus rate ( Figure  5Bb ). The LDCAE slope at the leading pacemaker site, which was located at different sites within the SAN during increasing doses of isoproterenol infusion, was also well correlated with the increase of sinus rate (online-only Data Supplement Figure IIIB ). Figure 6A compares the morphologies of Ca i tracing at SAN (sites 1 to 3) and RA (sites 4 to 5) during isoproterenol infusion. There were no morphological differences of Ca i tracings between the leading pacemaker sites and other RA sites at baseline before isoproterenol infusion (Figure 6Ab ).
Differential Responses of Different SAN Sites to Isoproterenol Infusion
Typical Ca i Dynamics of the Leading Pacemaker Sites During Isoproterenol Infusion
After isoproterenol infusion, the morphology of Ca i tracing at the leading pacemaker (site 1) was characterized not only by the earliest onset of LDCAE (asterisk) but also by the fastest Ca i reuptake (arrow) compared with other RA sites. The RA sites 4 to 5, for example, showed no LDCAE and a slower Ca i reuptake. The baseline 90% Ca i relaxation time was 279Ϯ70, 300Ϯ83, and 325Ϯ67 ms at superior, inferior SAN, and RA, respectively (Pϭ0.11). After isoproterenol infusion, the 90% Ca i relaxation time was shorter at superior SAN (124Ϯ34 ms) than at inferior SAN (138Ϯ24 ms; Pϭ0.01) and at other RA sites (164Ϯ33 ms; Pϭ0.001; Figure 6B ). The superior and inferior SAN were harvested and analyzed for total expression of SERCA2a and phospholamban after optical mapping studies. As shown in the immunoblot in Figure 6C , SERCA2a and phospholamban were present in both SAN and RA. The SERCA2a/ phospholamban ratio of RA (1.81Ϯ0.19) was higher than that of superior SAN (1.39Ϯ0.16; Pϭ0.006) and inferior SAN (1.51Ϯ0.15; Pϭ0.03; Figure 6D ).
Importance of SR Function on Pacemaking
Caffeine sensitizes the ryanodine receptor 2 to activation, resulting in increased SR Ca 2ϩ release. 10 High concentrations of caffeine will deplete the SR calcium store. Indeed, when a 2-mL caffeine bolus (20 mmol/L) was injected directly into the right coronary artery, LDCAE appeared in the superior SAN, and the sinus rate increased by 84% in 2 hearts (online-only Data Supplement Figure IVA) . However, after 10-minute continuous infusion, heart rate decreased, and LDCAE was abolished. Further isoproterenol infusion did not produce LDCAE (nϭ1). Continuous caffeine infusion at 0.2 and 0.5 mmol/L did not produce LDCAE (nϭ2; online-only Data Supplement Figure V) .
If the appearance of LDCAE faithfully tracks stimulation of the Ca 2ϩ clock, then agents that interfere with SR Ca 2ϩ cycling should suppress LDCAE. Figure 7A shows the dose-response curve for ryanodine on SAN pacemaking rate (nϭ3). Because the activation rate changes rapidly during the procedure, it was not possible to document the origin of the atrial activation of every beat. Therefore, we have analyzed the heart rate, rather than sinus rate, on the basis of pseudo-ECG recordings. Low doses of ryanodine (Ͻ0.3 mol/L), which sensitize ryanodine receptors to Ca 2ϩ -induced Ca 2ϩ release, resulted in a slight (Ͻ10%) increase in heart rate. Higher doses of ryanodine, which block ryanodine receptors, caused a dose-dependent suppression of sinus node activity. The isoproterenol dose-dependent increase of heart rate was suppressed by ryanodine infusion (Figure 7B ). Concomitant with these effects on heart rate, ryanodine pretreatment completely prevented isoproterenol-induced LDCAE (nϭ3; middle panel of Figure 7C ). Isoproterenol-induced LDCAE was also abolished with ryanodine (nϭ2; online-only Data Supplement Figure IVB) .
To fully suppress SR Ca 2ϩ cycling, we also studied the effects of ryanodine (10 mol/L) in combination with thapsigargin (200 nmol/L). After 30-minute pretreatment, the mean heart rate decreased by 54% from 94Ϯ4 to 44Ϯ7 bpm. Subsequent isoproterenol infusion (1 mol/L) increased the mean maximum heart rate to 112Ϯ13 bpm (18% over the baseline rate before ryanodine and thapsigargin). The heart rate increase was not associated with LDCAE (nϭ2; right panel of Figure 7C ).
In contrast to SR inhibitors, the I f blocker ZD 7288 (3 mol/L), which decreased the basal sinus rate by 8.3% (nϭ3), did not prevent isoproterenol from increasing sinus rate by 40%, accompanied by the appearance of LDCAE in the superior SAN ( Figure 7D ).
Together, these findings provide strong support that in intact SAN tissue, LDCAE faithfully reports Ca 2ϩ clock activity, as previously documented in isolated SAN myocytes. 4 -10 
Effects of SR Inhibition and I f Blockade on Sinus Rate and its Acceleration by Isoproterenol
If the voltage and Ca i clocks act interdependently and synergistically to support each other in determining SAN rate, then the effects of blocking one clock or the other are likely to be complex and not necessarily very informative. This was the case, as shown in Figure 8 , which summarizes the relative changes in heart rate caused by various pharmacological agents under basal conditions and during isoproterenol. Moreover, ryanodine and ryanodine plus thapsigargin often shifted the pacemaking site to outside of the SAN so that the source of activation was ectopic beats from outside of the mapped region. Therefore, the heart rate changes might underestimate the sinus node suppression by SR inhibition and overestimate the sinus node responses to isoproterenol. The exact magnitude of SAN suppression could not be determined because of the presence of competing ectopic rhythm.
Discussion
Major Findings
The present study supports the importance of spontaneous SR Ca 2ϩ release and the Ca 2ϩ clock to pacemaking in the intact canine SAN. Key findings include the demonstration of a robust LDCAE and its correlation with sinus rate acceleration during ␤-adrenergic stimulation, the demonstration of LDCAE during caffeine-induced sinus rate acceleration, and the concomitant suppression of isoproterenol-induced LDCAE and sinus rate acceleration by ryanodine and thapsigargin. In addition, sinus rate acceleration during isoproterenol infusion was partially (but not completely) blocked by ZD 7288, a specific I f current inhibitor. These findings have reproduced several key observations used to support the Ca 2ϩ clock hypothesis in isolated SAN myocytes and in intact dogs. 4 -11 In addition, we have demonstrated that isoproterenol infusion resulted in a superior shift of pacemaking site within the SAN, such that the leading pacemaking site always colocalized with the site with the most robust LDCAE. Together, these findings support the conclusion that spontaneous SR Ca 2ϩ release acts synergistically with activation of membrane ionic currents such as I f to accelerate the sinus rate in intact canine SAN during ␤-adrenergic stimulation.
Heterogeneous Ca i Dynamics in the SAN
Cells in different portions of the SAN exhibit a range of electrophysiological and Ca 2ϩ handling characteristics. 18 -21 Mapping intact RA to study SAN function has the advantage that differential responses to ␤-adrenergic stimulation and other interventions can be characterized regionally within the SAN and compared with RA. LDCAE was observed in only a small percentage of the preparations at baseline. One possible explanation of the latter finding is that the Ca 2ϩ clock lagged behind the voltage clock in regulating DD under basal conditions. Alternatively, because each pixel in an optical map contains information from multiple cells, the effects of spatial averaging might have prevented us from documenting smaller spontaneous SR Ca 2ϩ releases or Ca 2ϩ releases from individual SAN cells. The importance of SR Ca 2ϩ release on baseline heart rate is also supported by the finding that the impact of ryanodine and ryanodine plus thapsigargin on heart rate is much greater than the blockage of I f current alone. However, LDCAE occurred in all preparations during isoproterenol infusion, associated with a superior shift of the leading pacemaker site. The superior shift of LDCAE and the pacemaking site was also observed consistently with caffeine infusion. Most importantly, the site of maximum LDCAE slope always colocalized with the leading pacemaking site, suggesting a shift in which the voltage clock now lagged the Ca 2ϩ clock. This observation indicates a strong association between LDCAE and pacemaking during ␤-adrenergic stimulation and provides new insights into pacemaker hierarchy in the canine RA. 12, 13 
Mechanisms of DD
Multiple time-and voltage-dependent ionic currents have been identified in cardiac pacemaker cells that contribute to DD, including I Ca-L , I Ca-T , I ST , and various types of delayed rectifier K currents. 22 Many of these membrane currents are known to respond to ␤-adrenergic stimulation. Some of these currents, such as I Ca-L , also promote LDCAE and the acceleration of sinus rate by the Ca 2ϩ clock as well as the voltage clock. The interdependence and synergy between the 2 clocks is evident from the pharmacological responses (Figure 8 ). If the 2 clocks were independent, with the faster clock driving the heart rate under a given condition, then blocking the slower clock should have no effect on SAN rate, whereas blocking the faster clock should decrease the SAN rate to that of the slower clock (which could be either markedly or only slightly slower than the faster clock). However, because both SR inhibitors and I f blockade slowed sinus rate under basal conditions, as well as blunted the isoproterenol-induced increase in sinus rate, the hypothesis of independent clocks can be excluded. This is not surprising given that common ionic mechanisms, such as I Ca-L , are known to regulate both clocks. However, because the 2 clocks are interdependent, the relative potency of SR inhibition versus I f blockade on slowing sinus rate in Figure 8 becomes very difficult to interpret because interdependency implies that inhibiting the SR will affect the voltage clock as well as the Ca 2ϩ clock, and vice versa. The interpretation is further complicated by the presence of ectopic foci outside the mapped region during sinus node suppression. Thus, the presence or absence of LDCAE appears to be the most reliable indicator of which clock is predominantly driving the sinus rate under any given condition.
Ca i Sinkhole and the Mechanisms of Pacemaking
Hwang et al 15 previously reported that a Ca i sinkhole in the postshock period is the site for the first postshock activation that reinitiates ventricular fibrillation. In the present study, we found that a Ca i sinkhole is also present at the site of the earliest LDCAE and subsequent onset of the sinus activation. The formation of the Ca i sinkhole was facilitated by a rapid decline (short relaxation time) of Ca i fluorescence at the superior SAN during isoproterenol infusion. This finding suggests that Ca i reuptake by SR is the fastest in the superior SAN. Because the uptake at superior SAN was the fastest, it resulted in a low Ca i region surrounded by high Ca i region and the formation of Ca i sinkhole during early diastole ( Figure 3D ). More rapid and complete SR Ca 2ϩ reuptake may ensure that the same site is the earliest to spontaneously release Ca 2ϩ in the next cycle.
Differential SERCA2a/Phospholamban Ratio at SAN and RA
The key protein regulator of Ca uptake is phospholamban, which inhibits SERCA2a in its dephosphorylated state. ␤-Adrenergic stimulation phosphorylates phospholamban, reversing its inhibition of SERCA2a and increasing Ca 2ϩ uptake. In canine hearts, the SERCA2a/phospholamban molar ratio is estimated at Ϸ1:2, implying that at most only half of SERCA2a is inhibited by phospholamban in the basal state. 23, 24 We demonstrated in the present study that there was a significantly lower SERCA2a/phospholamban ratio at SAN sites than at RA sites, suggesting that more phospholamban molecules are available to regulate SERCA2a molecules in SAN than in RA. Isoproterenol infusion phosphorylates phospholamban and relieves phospholamban inhibition of SERCA2a, which may account for more robust Ca uptake in SAN than in RA during isoproterenol infusion. However, we did not directly measure the phosphorylation state of phospholamban before and after isoproterenol infusion to confirm this hypothesis.
Study Limitations
An important concern in applying dual optical mapping of V m and Ca i to a thin, slowly conducting tissue such as the intact SAN is whether the different dyes are imaging equivalent volumes of tissue because the dyes have different tissue penetration and scattering properties. 25 Because conduction velocity is very slow, this factor could distort the timing of the Ca 2ϩ transient relative to the voltage transient if the respective fluorescence signals were being recorded from nonidentical tissue layers. However, this concern is somewhat mitigated by the finding that the same sites that did not exhibit LDCAE under basal conditions developed LDCAE after isoproterenol, despite identical imaging parameters. Although motion artifact after isoproterenol infusion could potentially create an artifact, as shown in online-only Data Supplement Figure I , we documented that motion artifact was negligible in this study. We did not directly measure the SR Ca 2ϩ release. It is therefore possible that some components of LDCAE might have originated from the membrane Ca 2ϩ currents. However, LDCAE was completely suppressed by drugs that inhibited SR function. Finally, pharmacological agents such as ryanodine, thapsigargin, and ZD 7288 are not completely selective, and nonspecific effects cannot be excluded.
